Evidence map›Paper›PMID 40225751›Full record

ArticleJournal of tissue engineering and regenerative medicine2024

Targeting of C-ROS-1 Activity Using a Controlled Release Carrier to Treat Craniosynostosis in a Preclinical Model of Saethre-Chotzen Syndrome.

Esther Camp, Laura Gonzalez Garcia, Clara Pribadi, Sharon Paton, Krasimir Vasilev, Peter Anderson, Stan Gronthos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of tissue engineering and regenerative medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Esther CampMesenchymal Stem Cell Laboratory, School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Laura Gonzalez GarciaSchool of Engineering and Future Industries Institute, Mawson Lakes Campus, University of South Australia, Mawson Lakes, SA, Australia.
Clara PribadiMesenchymal Stem Cell Laboratory, School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Sharon PatonMesenchymal Stem Cell Laboratory, School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Krasimir VasilevSchool of Engineering and Future Industries Institute, Mawson Lakes Campus, University of South Australia, Mawson Lakes, SA, Australia.
Peter AndersonPrecision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
Stan GronthosMesenchymal Stem Cell Laboratory, School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.ORCID https://orcid.org/0000-0002-6225-3084

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Saethre-Chotzen syndrome (SCS) is one of the most prevalent craniosynostosis, caused by a loss-of-function mutation in the

Indexed as

AcrocephalosyndactyliaCraniosynostosesDrug CarriersAnimalsDelayed-Action PreparationsDisease Models, AnimalMiceDelayed-Action PreparationsDrug Carriers

Identifiers

PMID40225751
PMCPMC11919205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.